Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.7248
Delayed Data
As of Mar 24
 -0.0103 / -1.40%
Today’s Change
0.60
Today|||52-Week Range
3.27
+1.41%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.74
Today’s open0.77
Day’s range0.72 - 0.77
Volume470,992
Average volume (3 months)956,236
Market cap$4.8M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+44.29%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book0.53

Competitors

 Today’s
change
Today’s
% change
ROSGRosetta Genomics Ltd-0.57-15.04%
RGBPRegen BioPharma Inc-0.00-5.00%
CLSNCelsion Corp+0.00+1.52%
XTNTXtant Medical Holdin...-0.00-0.73%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMarch 31, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts


Search for Jobs